DNA methyltransferase inhibitors in hematological malignancies and solid tumors. [PDF]
Wenger V +3 more
europepmc +1 more source
Decitabine promotes degradation of DNMT1 and EZH2 via the ubiquitination pathway and inhibits colorectal cancer progression. [PDF]
Peng XM +7 more
europepmc +1 more source
Decitabine-cedazuridine in patients with MDS and TP53 mutations. [PDF]
Urrutia S +13 more
europepmc +1 more source
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancer. [PDF]
Preston-Alp S +9 more
europepmc +1 more source
Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia [PDF]
core +1 more source
Disordered DNA methylation leads to targetable transcriptional plasticity in ATRT. [PDF]
Tetens AR +10 more
europepmc +1 more source
Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow [PDF]
Bansal, Dhruv +9 more
core +3 more sources
American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. [PDF]
Sekeres MA +24 more
europepmc +1 more source
TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approaches. [PDF]
Deshpande S +6 more
europepmc +1 more source
The effect of decitabine on human induced pluripotent stem cells (hiPSCs) derived CD34<sup>+</sup> cells expansion and the megakaryocytes generation and maturation. [PDF]
Liu Y, Zhang H, Li Y, Zhao C.
europepmc +1 more source

